A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients

PURPOSE: This is the first clinical evaluation of a novel fluorescent imaging agent (Omocianine) for breast cancer detection with diffuse optical tomography (DOT). PROCEDURES: Eleven women suspected of breast cancer were imaged with DOT at multiple time points (up to 24 h) after receiving an intrave...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van de Ven, Stephanie, Wiethoff, Andrea, Nielsen, Tim, Brendel, Bernhard, van der Voort, Marjolein, Nachabe, Rami, Van der Mark, Martin, Van Beek, Michiel, Bakker, Leon, Fels, Lueder, Elias, Sjoerd, Luijten, Peter, Mali, Willem
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864903/
https://ncbi.nlm.nih.gov/pubmed/19798535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-009-0269-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados